Showing results (61-70 of 74) with videos related to
Sort By:
Pageof 8
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|June 1, 1995
Effect of testosterone administration, pre- and postnatally, on the immune system of ratsM M Konstadoulakis, K N Syrigos, C N Baxevanis, et al.International Journal of Radiation Oncology, Biology, Physics|June 8, 2001
The effect of irradiation on the biodistribution of radiolabeled pegylated liposomesK J Harrington, G Rowlinson-Busza, K N Syrigos, et al.British Journal of Cancer|August 17, 2000
Influence of tumour size on uptake of(111)ln-DTPA-labelled pegylated liposomes in a human tumour xenograft modelK J Harrington, G Rowlinson-Busza, K N Syrigos, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft modelK J Harrington, G Rowlinson-Busza, K N Syrigos, et al.In Vivo (Athens, Greece)|May 21, 2009
Gastrointestinal bleeding as initial presentation of melanoma of unknown primary origin: report of a case and review of the literatureE A Kotteas, A Adamopoulos, P D Drogitis, et al.Journal of Wound Care|August 16, 2011
Analgesic efficacy of an ibuprofen-releasing foam dressing compared with local best practice for painful exuding woundsV Arapoglou, K Katsenis, K N Syrigos, et al.British Journal of Cancer|June 17, 2004
Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft modelK J Harrington, K N Syrigos, P S Uster, et al.The Journal of Pathology|April 21, 1999
E-cadherin/catenin complex in benign and malignant melanocytic lesionsR Silye, A J Karayiannakis, K N Syrigos, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2009
Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancerK N Syrigos, J Vansteenkiste, P Parikh, et al.British Journal of Cancer|February 24, 2006
Gefitinib (ZD1839, Iressa) as palliative treatment in recurrent or metastatic head and neck cancerA M Kirby, R P A'Hern, C D'Ambrosio, et al.Pageof 8